about
Cardiac toxicity in cancer survivorsBirth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype.Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013Clinical guide to fertility preservation in hematopoietic cell transplant recipientsParental educational attainment as an indicator of socioeconomic status and risk of childhood cancers.Individual prediction of heart failure among childhood cancer survivors.Birth characteristics and childhood carcinomasEquivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia.Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort.Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation SurvivorsRisk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysisInfluence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantationPhysician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipientsCardiovascular disease in survivors of hematopoietic cell transplantation.Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation.Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.A Fitbit and Facebook mHealth intervention for promoting physical activity among adolescent and young adult childhood cancer survivors: A pilot study.Cardio-oncology Related to Heart Failure: Pediatric Considerations for Cardiac Dysfunction.Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.The July Effect on Maternal Peripartum Complications before and after Resident Duty Hour Reform: A Population-Based Retrospective Cohort Study.Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.Parental Age and Risk of Infant Leukaemia: A Pooled Analysis.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer.Adipokines, Inflammation, and Adiposity in Hematopoietic Cell Transplantation Survivors.A threshold-free summary index of prediction accuracy for censored time to event data.Obesity and hypertension among children after treatment for acute lymphoblastic leukemia.Patient-reported outcomes and health status associated with chronic graft--host diseaseHypothyroidism after Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor StudyOptimization of Health and Extension of Lifespan Through Childhood Cancer Survivorship ResearchCardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and PreventionNew Agents, Emerging Late Effects, and the Development of Precision SurvivorshipSeverity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone healthPrediction of cardiovascular disease among hematopoietic cell transplantation survivors
P50
Q26851957-0E7A31F9-A796-4D4E-B45A-EF0BE70FC0EDQ33620152-40F7904A-A841-4154-AE4C-0FDACF640C98Q33778674-849541D1-6D26-4B9B-B3AB-64ECD76484D6Q33809651-28E1D407-6B91-4DEE-9436-C8D04ADECA59Q34000261-7694AAA5-8CE1-4FD0-81DD-601EDF149062Q35040680-C6F41539-8843-486F-A680-3B3663AA8511Q35620612-17A581C8-73F2-4368-87D8-6AB10FB73536Q35754395-A69BB099-F466-430A-862A-DB1DC5C3FF2DQ35947024-D2897169-A9B8-4693-8A6E-F5BFE7ABCA84Q36598564-E3CE5AEA-CE38-43F0-9B08-01411A0968F7Q36783762-7DC524B1-EE94-41AC-BE50-8D47903A37F3Q37004233-C21D611B-4092-4EC2-80E6-75E1011BB5A1Q37159230-7115A18A-81CA-4D5B-9993-9DDF8A7EAB0CQ37268680-548760F2-77D9-4947-9C16-7A95598491F3Q37379325-D96BF45A-9E61-438C-8C32-F9096E427557Q37460433-026CB1B0-9A2A-48DE-A74A-4E11B368AF2AQ37556136-69406810-8A23-46B7-9AE8-4EFF64BD6CE7Q37624268-8B6B8CCD-279D-4CD8-96C3-259CD94A0C2BQ37885168-B1D55F19-8365-4966-995B-7EAFF8BCC5B5Q38688824-2792FF6E-714A-4B69-A497-28E4469BEADDQ38724156-B28750F9-6C57-4C28-832B-0D63B51F4F29Q39171493-A2DD8493-99BE-4107-8486-9CDFC3D940ABQ39732493-344E0DB7-5F3C-4FCF-B865-67517DD77031Q40330104-5C05C503-1E45-4A58-8988-8988B468F723Q40629596-CC35ECD8-AF17-468A-A860-35DA22DD2AD9Q46001555-1E1B3862-D6D9-43B9-A50F-B0220FABEC6BQ46181268-C8740978-4661-485A-8428-0B2EBA88EFB7Q47588548-E0AB7851-D018-4ACC-B140-B91A9EF00546Q47743601-49665957-22E8-4E5E-A117-84FB9F21FD2CQ47863728-3D834855-BF02-4349-AE95-D330D7B8A315Q49346553-CD753BC3-02C8-4914-89F4-147701C22810Q50052080-E1C8BBFB-CD9F-48E5-88F0-B6AEF218C19DQ53525313-6B848406-1C28-4A4C-969D-109A351BB462Q58777001-E394E201-C67C-4D69-8490-C7EB4DBF2A14Q88679089-656DA91B-C3EA-46A1-9351-838911B56CB3Q89009968-D77470A7-3195-4EB1-B6AB-65FD11367A5CQ89009991-EC6FA260-0997-41DE-B77D-81B422325022Q89009994-1C42CB3A-B142-4750-8E37-7AC19D0BE2FCQ90179278-1D1DBFB2-6C6D-400A-BAB3-5771A79316CAQ90424728-628A2B0F-A626-4218-816D-CA7A50044B92
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Eric J Chow
@en
Eric J Chow
@nl
type
label
Eric J Chow
@en
Eric J Chow
@nl
prefLabel
Eric J Chow
@en
Eric J Chow
@nl
P31
P496
0000-0001-7712-961X